S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 181 to 240 of 298

Issue Date	Title / Author(s) / Citation	File
2013-11	Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study Ohtsu, Atsushi; Ajani, Jaffer A.; Bai, Yu-Xian; Bang, Yung-Jue; Chung, Hyun-Cheol; Pan, Hong-Ming; Sahmoud, Tarek; Shen, Lin; Yeh, Kun-Huei; Chin, Keisho; Muro, Kei; Kim, Yeul Hong; Ferry, David; Tebbutt, Niall C.; Al-Batran, Salah-Eddin; Smith, Heind; Costantini, Chiara; Rizvi, Syed; Lebwohl, David; Van Cutsem, Eric Journal of Clinical Oncology, Vol.31 No.31, pp.3935-3943	DOI
2013-11	Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis Paoletti, Xavier; Oba, Koji; Bang, Yung-Jue; Bleiberg, Harry; Boku, Narikazu; Bouche, Olivier; Catalano, Paul; Fuse, Nozomu; Michiels, Stefan; Moehler, Markus; Morita, Satoshi; Ohashi, Yasuo; Ohtsu, Atsushi; Roth, Arnaud; Rougier, Philippe; Sakamoto, Junichi; Sargent, Daniel; Sasako, Mitsuru; Shitara, Kohei; Thuss-Patience, Peter; Van Cutsem, Eric; Burzykowski, Tomasz; Buyse, Marc Journal of the National Cancer Institute, Vol.105 No.21, pp.1667-1670	DOI
2013-11	Disease-Free Survival as a Surrogate for Overall Survival in Adjuvant Trials of Gastric Cancer: A Meta-Analysis Oba, Koji; Paoletti, Xavier; Alberts, Steven; Bang, Yung-Jue; Benedetti, Jacqueline; Bleiberg, Harry; Catalano, Paul; Lordick, Florian; Michiels, Stefan; Morita, Satoshi; Ohashi, Yasuo; Pignon, Jean-pierre; Rougier, Philippe; Sasako, Mitsuru; Sakamoto, Junichi; Sargent, Daniel; Shitara, Kohei; Cutsem, Eric Van; Buyse, Marc; Burzykowski, Tomasz Journal of the National Cancer Institute, Vol.105 No.21, pp.1600-1607	DOI
2013-12	Registry of gastric cancer treatment evaluation (REGATE): II treatment practice Ter-Ovanesov, Mikhail; Yalcin, Suayib; Zalcberg, John; Hitier, Simon; Bang, Yung-Jue; Wu, Chew-Wun; Roth, Arnaud Asia-Pacific Journal of Clinical Oncology, Vol.9 No.4, pp.373-380	DOI
2013-12	Phase I study of sunitinib plus capecitabine/cisplatin or capecitabine/oxaliplatin in advanced gastric cancer Lee, K. -W.; Park, S. R.; Oh, D. -Y.; Park, Y. -I.; Khosravan, R.; Lin, X.; Lee, S. -Y.; Roh, E. -J.; Valota, O.; Lechuga, M. J.; Bang, Y. -J. Investigational New Drugs, Vol.31 No.6, pp.1547-1558	DOI
2014-03	Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics Bang, Yung-Jue; Yalcin, Suayib; Roth, Arnaud; Hitier, Simon; Ter-Ovanesov, Mikhail; Wu, Chew-Wun; Zalcberg, John Asia-Pacific Journal of Clinical Oncology, Vol.10 No.1, pp.38-52	DOI
2014-07	Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTANA- A Randomized, Phase III Study Satoh, Taroh; Xu, Rui-Hua; Chung, Hyun Cheol; Sun, Guo-Ping; Doi, Toshihiko; Xu, Jian-Ming; Tsuji, Akihito; Omuro, Yasushi; Li, Jin; Wang, Jin-Wan; Miwa, Hiroto; Qin, Shu-Kui; Chung, Ik-Joo; Yeh, Kun-Huei; Feng, Ji-Feng; Mukaiyama, Akihira; Kobayashi, Mikiro; Ohtsu, Atsushi; Bang, Yung-Jue Journal of Clinical Oncology, Vol.32 No.19, pp.2039-U89	DOI
2014-07	Quality of Life in the Trastuzumab for Gastric Cancer Trial Satoh, Taroh; Bang, Yung-Jue; Gotovkin, Evgeny A.; Hamamoto, Yasuo; Kang, Yoon-Koo; Moiseyenko, Vladimir M.; Ohtsu, Atsushi; Van Cutsem, Eric; Al-Sakaff, Nedal; Urspruch, Alexa; Hill, Julie; Weber, Harald A.; Chung, Hyun-Cheol Oncologist, Vol.19 No.7, pp.712-719	DOI
2014-08	A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer Kang, Y-K; Rha, S. Y.; Tassone, P.; Barriuso, J.; Yu, R.; Szado, T.; Garg, A.; Bang, Y-J British Journal of Cancer, Vol.111 No.4, pp.660-666	DOI
2014-09	Sunitinib in metastatic renal cell carcinoma: An ethnic Asian subpopulation analysis for safety and efficacy Lee, Se-Hoon; Bang, Yung-Jue; Mainwaring, Paul; Ng, Christina; Chang, John W-C; Kwong, Philip; Li, Rubi K.; Sriuranpong, Virote; Toh, Chee-Keong; Yuan, Jinyu; Pitman Lowenthal, Susan; Chung, Hyun C. Asia-Pacific Journal of Clinical Oncology, Vol.10 No.3, pp.237-245	DOI
2014-09	Prediction of survival in terminally ill cancer patients at the time of terminal cancer diagnosis Kim, Yu Jung; Kim, Su-Jung; Lee, June Koo; Choi, Won-Suk; Park, Jin Hyun; Kim, Hee Jun; Sim, Sung Hoon; Lee, Keun-Wook; Lee, Se-Hoon; Kim, Jee Hyun; Kim, Dong-Wan; Lee, Jong Seok; Bang, Yung-Jue; Heo, Dae Seog Journal of Cancer Research and Clinical Oncology, Vol.140 No.9, pp.1567-1574	DOI
2014-11	Crizotinib in ROS1-Rearranged Non-Small-Cell Lung Cancer Shaw, Alice T.; Ou, Sai-Hong I.; Bang, Yung-Jue; Camidge, D. Ross; Solomon, Benjamin J.; Salgia, Ravi; Riely, Gregory J.; Varella-Garcia, Marileila; Shapiro, Geoffrey I.; Costa, Daniel B.; Doebele, Robert C.; Long Phi Le; Zheng, Zongli; Tan, Weiwei; Stephenson, Patricia; Shreeve, S. Martin; Tye, Lesley M.; Christensen, James G.; Wilner, Keith D.; Clark, Jeffrey W.; Iafrate, A. John New England Journal of Medicine, Vol.371 No.21, pp.1963-1971	DOI
2014-11	A multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma Kim, Dong-Wan; Oh, Do-Youn; Shin, Seong Hoon; Kang, Jin Hyoung; Cho, Byoung Chul; Chung, Joo-Seop; Kim, HyeJin; Park, Keon Uk; Kwon, Jung Hye; Han, Ji-Youn; Kim, Mi-Jung; Bang, Yung-Jue BMC Cancer, Vol.14, p. 795	view file DOI
2014-11	Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial Noh, Sung Hoon; Park, Sook Ryun; Yang, Han-Kwang; Chung, Hyun Cheol; Chung, Ik-Joo; Kim, Sang-Woon; Kim, Hyung-Ho; Choi, Jin-Hyuk; Kim, Hoon-Kyo; Yu, Wansik; Lee, Jong Inn; Shin, Dong Bok; Ji, Jiafu; Chen, Jen-Shi; Lim, Yunni; Ha, Stella; Bang, Yung-Jue; the CLASSIC trial investigators The Lancet Oncology, Vol.15 No.12, pp.1389-1396	DOI
2015-03	Treatment for unresectable gastric cancer Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue 대한의사협회지, Vol.58 No.3, pp.209-215	DOI
2015-07	HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer Van Cutsem, Eric; Bang, Yung-Jue; Feng-Yi, Feng; Xu, Jian M.; Lee, Keun-Wook; Jiao, Shun-Chang; Chong, Jorge Leon; Lopez-Sanchez, Roberto I.; Price, Timothy; Gladkov, Oleg; Stoss, Oliver; Hill, Julie; Ng, Vivian; Lehle, Michaela; Thomas, Marlene; Kiermaier, Astrid; Rueschoff, Josef Gastric Cancer, Vol.18 No.3, pp.476-484	DOI
2015-08	Pharmacodynamics and pharmacokinetics of oral topotecan in patients with advanced solid tumours and impaired renal function Devriese, Lot A.; Witteveen, Petronella (Els) O.; Mergui-Roelvink, Marja; Smith, Deborah A.; Lewis, Lionel D.; Mendelson, David S.; Bang, Yung-Jue; Chung, Hyun Choel; Dar, Mohammed M.; Huitema, Alwin D. R.; Beijnen, Jos H.; Voest, Emile E.; Schellens, Jan H. M. British Journal of Clinical Pharmacology, Vol.80 No.2, pp.253-266	DOI
2015-08	Phase 2 study of dovitinib in patients with metastatic or unresectable adenoid cystic carcinoma Keam, Bhumsuk; Kim, Sung-Bae; Shin, Seong Hoon; Cho, Byoung Chul; Lee, Keun-Wook; Kim, Min Kyoung; Yun, Hwan-Jung; Lee, Se-Hoon; Yoon, Dok Hyun; Bang, Yung-Jue Cancer, Vol.121 No.15, pp.2612-2617	DOI
2015-10	High ratio of programmed cell death protein 1 (PD-1)(+)/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy Lim, Yu Jin; Koh, Jaemoon; Kim, Kyubo; Chie, Eui Kyu; Kim, BoKyong; Lee, Kyoung Bun; Jang, Jin-Young; Kim, Sun-Whe; Oh, Do-Youn; Bang, Yung-Jue; Ha, Sung W. Radiotherapy and Oncology, Vol.117 No.1, pp.165-170	DOI
2015-10	Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors Oh, Do-Youn; Lee, Se-Hoon; Han, Sae-Won; Kim, Mi-Jung; Kim, Tae-Min; Kim, Tae-You; Heo, Dae Seog; Yuasa, Miyuki; Yanagihara, Yasuo; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.4, pp.607-615	DOI
2015-10	Phase I Study of Axitinib in Combination with Cisplatin and Capecitabine in Patients with Previously Untreated Advanced Gastric Cancer Oh, Do-Youn; Doi, Toshihiko; Shirao, Kuniaki; Lee, Keun-Wook; Park, Sook Ryun; Chen, Ying; Yang, Liqiang; Valota, Olga; Bang, Yung-Jue Cancer Research and Treatment, Vol.47 No.4, pp.687-696	DOI
2015-11	Effect of lapatinib on oral digoxin absorption in patients Koch, Kevin M.; Smith, Deborah A.; Botbyl, Jeff; Arya, Nikita; Briley, Linda P.; Cartee, Leanne; White, Jane Holshouser; Beyer, Jennifer; Dar, Mohammed M.; Chung, Hyun Choel; Chu, Quincy; Bang, Yung-Jue Clinical Pharmacology in Drug Development, Vol.4 No.6, pp.449-453	DOI
2015-12	Capecitabine for the treatment of gastric cancer Kim, Tae-Yong; Oh, Do-Youn; Bang, Yung-Jue Expert Review of Gastroenterology and Hepatology, Vol.9 No.12, pp.1471-1481	DOI
2016-01	Phase I study of CKD-516, a novel vascular disrupting agent, in patients with advanced solid tumors Oh, Do-Youn; Kim, Tae-Min; Han, Sae-Won; Shin, Dong-Yeop; Lee, Yun Gyoo; Lee, Keun-Wook; Kim, Jee Hyun; Kim, Tae-You; Jang, In-Jin; Lee, Jong-Seok; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.1, pp.28-36	DOI
2016-02	Pertuzumab in gastrointestinal cancer Oh, Do-Youn; Bang, Yung-Jue Expert Opinion on Biological Therapy, Vol.16 No.2, pp.243-253	DOI
2016-02	Lapatinib in combination with capecitabine plus oxaliplatin in human epidermal growth factor receptor 2-positive advanced or metastatic gastric, esophageal, or gastroesophageal adenocarcinoma: TRIO-013/LOGiC-A randomized phase III trial Hecht, J. Randolph; Bang, Yung-Jue; Qin, Shukui K.; Chung, Hyun C.; Xu, Jianming M.; Park, Joon O.; Jeziorski, Krzysztof; Shparyk, Yaroslav; Hoff, Paulo M.; Sobrero, Alberto; Salman, Pamela; Li, Jin; Protsenko, Svetlana A.; Wainberg, Zev A.; Buyse, Marc; Afenjar, Karen; Houe, Vincent; Garcia, Agathe; Kaneko, Tomomi; Huang, Yingjie; Khan-Wasti, Saba; Santillana, Sergio; Press, Michael F.; Slamon, Dennis Journal of Clinical Oncology, Vol.34 No.5, pp.443-451	DOI
2016-03	Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): A phase 3, randomised controlled trial Fujitani, Kazumasa; Yang, Han-Kwang; Mizusawa, Junki; Kim, Young-Woo; Terashima, Masanori; Han, Sang-Uk; Iwasaki, Yoshiaki; Hyung, Woo Jin; Takagane, Akinori; Park, Do Joong; Yoshikawa, Takaki; Hahn, Seokyung; Nakamura, Kenichi; Park, Cho Hyun; Kurokawa, Yukinori; Bang, Yung-Jue; Park, Byung Joo; Sasako, Mitsuru; Tsujinaka, Toshimasa The Lancet Oncology, Vol.17 No.3, pp.309-318	DOI
2016-04	VEGF and Ki-67 overexpression in predicting poor overall survival in adenoid cystic carcinoma Park, Seongyeol; Nam, Soo Jeong; Keam, Bhumsuk; Kim, Tae Min; Jeon, Yoon Kyung; Lee, Se-Noon; Hah, J. Hun; Kwon, Tack-Kyun; Kim, Dong-Wan; Sung, Myung-Whun; Heo, Dae Seog; Bang, Yung-Jue Cancer Research and Treatment, Vol.48 No.2, pp.518-526	view file DOI
2016-06	Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial Muro, Kei; Chung, Hyun Cheol; Shankaran, Veena; Geva, Ravit; Catenacci, Daniel; Gupta, Shilpa; Eder, Joseph Paul; Golan, Talia; Le, Dung T.; Burtness, Barbara; McRee, Autumn J.; Lin, Chia-Chi; Pathiraja, Kumudu; Lunceford, Jared; Emancipator, Kenneth; Juco, Jonathan; Koshiji, Minori; Bang, Yung-Jue The Lancet Oncology, Vol.17 No.6, pp.717-726	DOI
2016-07	A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumors Doi, Toshihiko; Lee, Kyung-Hun; Kim, Tae-Min; Ohtsu, Atsushi; Kim, Tae Yong; Ikeda, Masafumi; Yoh, Kiyotaka; Stampino, Corrado Gallo; Hirohashi, Tomoko; Suzuki, Akiyuki; Fujii, Yosuke; Williams, James Andrew; Bang, Yung-Jue Cancer Medicine, Vol.5 No.7, pp.1454-1463	DOI
2016-08	Regorafenib for the treatment of advanced gastric cancer (INTEGRATE): A multinational placebo-controlled phase II Trial Pavlakis, Nick; Sjoquist, Katrin M.; Martin, Andrew J.; Tsobanis, Eric; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Alcindor, Thierry; O'Callaghan, Christopher J.; Burnell, Margot J.; Tebbutt, Niall C.; Rha, Sun Young; Lee, Jeeyun; Cho, Jae-Yong; Lipton, Lara R.; Wong, Mark; Strickland, Andrew; Kim, Jin Won; Zalcberg, John R.; Simes, John; Goldstein, David Journal of Clinical Oncology, Vol.34 No.23, pp.2728-2728	DOI
2016-10	Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH Catenacci, Daniel V. T.; Liao, Wei-Li; Zhao, Lei; Whitcomb, Emma; Henderson, Les; O'Day, Emily; Xu, Peng; Thyparambil, Sheeno; Krizman, David; Bengali, Kathleen; Uzzell, Jamar; Darfler, Marlene; Cecchi, Fabiola; Blackler, Adele; Bang, Yung-Jue; Hart, John; Xiao, Shu-Yuan; Lee, Sang Mee; Burrows, Jon; Hembrough, Todd Gastric Cancer, Vol.19 No.4, pp.1066-1079	DOI
2016-12	Patient-Reported Outcomes and Quality of Life with Sunitinib Versus Placebo for Pancreatic Neuroendocrine Tumors: Results From an International Phase III Trial Vinik, Aaron; Bottomley, Andrew; Korytowsky, Beata; Bang, Yung-Jue; Raoul, Jean-Luc; Valle, Juan W.; Metrakos, Peter; Hoersch, Dieter; Mundayat, Rajiv; Reisman, Arlene; Wang, Zhixiao; Chao, Richard C.; Raymond, Eric Targeted Oncology, Vol.11 No.6, pp.815-824	DOI
2017-01	HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-O13/LOGiC Trial of Lapatinib Press, Michael F.; Ellis, Catherine E.; Gagnon, Robert C.; Grob, Tobias J.; Buyse, Marc; Villalobos, Ivonne; Liang, Zhiyong; Wu, Shafei; Bang, Yung-Jue; Qin, Shu-Kui; Chung, Hyun Cheol; Xu, Jianming; Park, Joon Oh; Jeziorski, Krzysztof; Afenjar, Karen; Ma, Yanling; Estrada, Monica C.; Robinson, Douglas M.; Scherer, Stefan J.; Sauter, Guido; Hecht, J. Randolph; Slamon, Dennis J. Molecular Cancer Therapeutics, Vol.16 No.1, pp.228-238	DOI
2017-02	The effect of anti-angiogenic agents on overall survival in metastatic oesophago-gastric cancer: A systematic review and meta-analysis Chan, David L.; Sjoquist, Katrin M.; Goldstein, David; Price, Timothy J.; Martin, Andrew J.; Bang, Yung-Jue; Kang, Yoon-Koo; Pavlakis, Nick PLoS ONE, Vol.12 No.2, p. e0172307	DOI
2017-02	Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study Faivre, S.; Niccoli, P.; Castellano, D.; Valle, J. W.; Hammel, P.; Raoul, J. -L.; Vinik, A.; Van Cutsem, E.; Bang, Y. -J.; Lee, S. -H.; Borbath, I.; Lombard-Bohas, C.; Metrakos, P.; Smith, D.; Chen, J. -S.; Ruszniewski, P.; Seitz, J. -F.; Patyna, S.; Lu, D. R.; Ishak, K. J.; Raymond, E. Annals of Oncology, Vol.28 No.2, pp.339-343	DOI
2017-04	Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy Lim, Yu Jin; Koh, Jaemoon; Kim, Kyubo; Chie, Eui Kyu; Kim, Sehui; Lee, Kyoung Bun; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Bang, Yung-Jue Targeted Oncology, Vol.12 No.2, pp.211-218	DOI
2017-04	Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single Institution Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Kwon, Jeanny; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.2, pp.473-483	DOI
2017-05	Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma The METGastric Randomized Clinical Trial Shah, Manish A.; Bang, Yung-Jue; Lordick, Florian; Alsina, Maria; Chen, Meng; Hack, Stephen P.; Bruey, Jean Marie; Smith, Dustin; McCaffery, Ian; Shames, David S.; Phan, See; Cunningham, David JAMA oncology, Vol.3 No.5, pp.620-627	DOI
2017-05	Risk stratification and prognostic nomogram for postrecurrence overall survival in patients with recurrent extrahepatic cholangiocarcinoma Kim, Byoung Hyuck; Kim, Kyubo; Chie, Eui Kyu; Kwon, Jeanny; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Bang, Yung-Jue HPB, Vol.19 No.5, pp.421-428	DOI
2017-06	Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer Secondary Analysis of the TRIO-013/LOGiC Randomized Clinical Trial Chu, Michael P.; Hecht, J. Randolph; Slamon, Dennis; Wainberg, Zev A.; Bang, Yung-Jue; Hoff, Paulo M.; Sobrero, Alberto; Qin, Shukui; Afenjar, Karen; Houe, Vincent; King, Karen; Koski, Sheryl; Mulder, Karen; Hiller, Julie Price; Scarfe, Andrew; Spratlin, Jennifer; Huang, Yingjie J.; Khan-Wasti, Saba; Chua, Neil; Sawyer, Michael B. JAMA oncology, Vol.3 No.6, pp.767-773	DOI
2017-06	A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification Van Cutsem, E.; Bang, Y. -J.; Mansoor, W.; Petty, R. D.; Chao, Y.; Cunningham, D.; Ferry, D. R.; Smith, N. R.; Frewer, P.; Ratnayake, J.; Stockman, P. K.; Kilgour, E.; Landers, D. Annals of Oncology, Vol.28 No.6, pp.1316-1324	DOI
2017-06	Resistance Mechanism against Trastuzumab in HER2-Positive Cancer Cells and Its Negation by Src Inhibition Jin, Mei Hua; Nam, Ah-Rong; Park, Ji Eun; Bang, Ju-Hee; Bang, Yung-Jue; Oh, Do-Youn Molecular Cancer Therapeutics, Vol.16 No.6, pp.1145-1154	DOI
2017-06	Prospective Evaluation of Changes in Tumor Size and Tumor Metabolism in Patients with Advanced Gastric Cancer Undergoing Chemotherapy: Association and Clinical Implication Park, Seongyeol; Ha, Seunggyun; Kwon, Hyun Woo; Kim, Woo Hyoung; Kim, Tae-Yong; Oh, Do-Youn; Cheon, Gi Jeong; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.58 No.6, pp.899-904	DOI
2017-07	Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea Carter, Gebra Cuyun; Kaltenboeck, Anna; Ivanova, Jasmina; Liepa, Astra M.; Roman, Alexandra San; Koh, Maria; Rajan, Narayan; Cheng, Rebecca; Birnbaum, Howard G.; Kim, Jong Seok; Bang, Yung-Jue Cancer Research and Treatment, Vol.49 No.3, pp.578-587	DOI
2017-07	Findings of a 1303 Korean whole-exome sequencing study Kwak, Soo Heon; Chae, Jeesoo; Choi, Seongmin; Kim, Min Jung; Choi, Murim; Chae, Jong-Hee; Cho, Eun-hae; Hwang, Tai Ju; Jang, Se Song; Kim, Jong-Il; Park, Kyong Soo; Bang, Yung-Jue Experimental and Molecular Medicine, Vol.49, p. e356	DOI
2017-08	Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study Ott, Patrick A.; Bang, Yung-Jue; Berton-Rigaud, Dominique; Elez, Elena; Pishvaian, Michael J.; Rugo, Hope S.; Puzanov, Igor; Mehnert, Janice M.; Aung, Kyaw L.; Lopez, Juanita; Carrigan, Marion; Saraf, Sanatan; Chen, Mei; Soria, Jean-Charles Journal of Clinical Oncology, Vol.35 No.22, pp.2535-2541	DOI
2017-08	HELOISE: Phase IIIb Randomized Multicenter Study Comparing Standard-of-Care and Higher-Dose Trastuzumab Regimens Combined With Chemotherapy as First-Line Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Shah, Manish A.; Xu, Rui-hua; Bang, Yung-Jue; Hoff, Paulo M.; Liu, Tianshu; Herraez-Baranda, Luis A.; Xia, Fan; Garg, Amit; Shing, Mona; Tabernero, Josep Journal of Clinical Oncology, Vol.35 No.22, pp.2558-2567	DOI
2017-08	A Phase 1 Study of LY2874455, an Oral Selective pan-FGFR Inhibitor, in Patients with Advanced Cancer Michael, Michael; Bang, Yung-Jue; Park, Young Suk; Kang, Yoon-Koo; Kim, Tae Min; Hamid, Oday; Thornton, Donald; Tate, Sonya C.; Raddad, Eyas; Tie, Jeanne Targeted Oncology, Vol.12 No.4, pp.463-474	DOI
2017-08	Prospective Evaluation of the Clinical Implications of the Tumor Metabolism and Chemotherapy-Related Changes in Advanced Biliary Tract Cancer Jo, Jaemin; Kwon, Hyun Woo; Park, Seongyeol; Oh, Do-Youn; Cheon, Gi Jeong; Bang, Yung-Jue Journal of Nuclear Medicine, Vol.58 No.8, pp.1255-1261	DOI
2017-09	Prognostic relevance of lymph node status for patients with ampullary adenocarcinoma after radical resection followed by adjuvant treatment Kwon, J.; Kim, K.; Chie, E. K.; Kim, B. H.; Jang, J. -Y.; Kim, S. W.; Oh, D. -Y.; Bang, Y. -J. European Journal of Surgical Oncology, Vol.43 No.9, pp.1690-1696	DOI
2017-09	Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution Kim, Byoung Hyuck; Chie, Eui Kyu; Kim, Kyubo; Jang, Jin-Young; Kim, Sun Whe; Oh, Do-Youn; Bang, Yung-Jue; Ha, Sung W. Oncotarget, Vol.8 No.44, pp.78076-78085	DOI
2017-09	A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer Reynolds, Kerry Lynn; Bedard, Philippe L.; Lee, Se-Hoon; Lin, Chia-Chi; Tabernero, Josep; Alsina, Maria; Cohen, Ezra; Baselga, Jose; Blumenschein, George, Jr.; Graham, Donna M.; Garrido-Laguna, Ignacio; Juric, Dejan; Sharma, Sunil; Salgia, Ravi; Seroutou, Abdelkader; Tian, Xianbin; Fernandez, Rose; Morozov, Alex; Sheng, Qing; Ramkumar, Thiruvamoor; Zubel, Angela; Bang, Yung-Jue BMC Cancer, Vol.17, p. 646	view file DOI
2017-10	Phase I dose-escalation study of the c-Met tyrosine kinase inhibitor SAR125844 in Asian patients with advanced solid tumors, including patients with MET-amplified gastric cancer Shitara, Kohei; Kim, Tae Min; Yokota, Tomoya; Goto, Masahiro; Satoh, Taroh; Ahn, Jin-Hee; Kim, Hyo Song; Assadourian, Sylvie; Gomez, Corinne; Harnois, Marzia; Hamauchi, Satoshi; Kudo, Toshihiro; Doi, Toshihido; Bang, Yung-Jue Oncotarget, Vol.8 No.45, pp.79546-79555	DOI
2017-10	A first-time-in-human study of GSK2636771, a phosphoinositide 3 kinase beta-selective inhibitor, in patients with advanced solid tumors Mateo, Joaquin; Ganji, Gopinath; Lemech, Charlotte; Burris, Howard A.; Han, Sae-Won; Swales, Karen; Decordova, Shaun; DeYoung, M. Phillip; Smith, Deborah A.; Kalyana-Sundaram, Shanker; Wu, Jiuhua; Motwani, Monica; Kumar, Rakesh; Tolson, Jerry M.; Rha, Sun Young; Chung, Hyun Cheol; Eder, Joseph P.; Sharma, Sunil; Bang, Yung-Jue; Infante, Jeffrey R.; Yan, Li; de Bono, Johann S.; Arkenau, Hendrik-Tobias Clinical Cancer Research, Vol.23 No.19, pp.5981-5992	DOI
2017-10	Efficacy of sequential ipilimumab monotherapy versus best supportive care for unresectable locally advanced/metastatic gastric or gastroesophageal junction cancer Bang, Yung-Jue; Cho, Jae Yong; Kim, Yeul Hong; Kim, Jin Won; Di Bartolomeo, Maria; Ajani, Jaffer A.; Yamaguchi, Kensei; Balogh, Agnes; Sanchez, Teresa; Moehler, Markus Clinical Cancer Research, Vol.23 No.19, pp.5671-5678	DOI
2017-12	Change in carbohydrate antigen 19-9 level as a prognostic marker of overall survival in locally advanced pancreatic cancer treated with concurrent chemoradiotherapy Kim, Yi-Jun; Koh, Hyeon Kang; Chie, Eui Kyu; Oh, Do-Youn; Bang, Yung-Jue; Nam, Eun Mi; Kim, Kyubo International Journal of Clinical Oncology, Vol.22 No.6, pp.1069-1075	DOI
2017-12	Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer Jin, Ling; Jin, Mei-hua; Nam, Ah-Rong; Park, Ji-Eun; Bang, Ju-Hee; Oh, Do Yeun; Bang, Yung Jue Cancer Letters, Vol.411, pp.162-170	DOI
2018-01	S-1-induced lacrimal drainage obstruction and its association with ingredients/metabolites of S-1 in tears and plasma: A prospective multi-institutional study Kim, Namju; Kim, Jin Won; Baek, Je-Hyun; Kim, Jin-Soo; Choung, Ho-Kyung; Kim, Tae-Yong; Lee, Kyung-Hun; Bang, Yung-Jue; Khwarg, Sang In; Ahn, Sang-Hoon; Park, Do Joong; Kim, Hyung-Ho; Chung, Jae-Yong; Ahn, Soyeon; Lee, Keun-Wook Cancer Research and Treatment, Vol.50 No.1, pp.30-39	DOI
2018-01	Safety and antitumor activity of pembrolizumab in advanced programmed death Ligand 1-positive endometrial cancer: Results from the KEYNOTE-028 study Ott, Patrick A.; Bang, Yung-Jue; Berton-Rigaud, Dominique; Elez, Elena; Pishvaian, Michael J.; Rugo, Hope S.; Puzanov, Igor; Mehnert, Janice M.; Aung, Kyaw L.; Lopez, Juanita; Carrigan, Marion; Saraf, Sanatan; Chen, Mei; Soria, Jean-Charles Obstetrical and Gynecological Survey, Vol.73 No.1, pp.26-27	DOI

1 2 3 4 5